These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7719619)

  • 21. Idiotype- and anti-idiotype-reactive T lymphocytes in myasthenia gravis. Evidence for the involvement of different subpopulations of T helper lymphocytes.
    Yi Q; Lefvert AK
    J Immunol; 1994 Oct; 153(7):3353-9. PubMed ID: 8089503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of antibody production by helper T cell clones in experimental autoimmune myasthenia gravis.
    Fujii Y; Lindstrom J
    J Immunol; 1988 Nov; 141(10):3361-9. PubMed ID: 2972772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response gene control of lymphocyte proliferation induced by acetylcholine receptor-specific helper factor derived from lymphocytes of myasthenic mice.
    Christadoss P; Lindstrom JM; Talal N; Duvic CR; Kalantri A; Shenoy M
    J Immunol; 1986 Sep; 137(6):1845-9. PubMed ID: 2943805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of interferon-gamma, interleukin-4, and transforming growth factor-beta in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Link H; Ljungdahl A; Höjeberg B; Link J; He B; Qiao J; Melms A; Olsson T
    Cell Immunol; 1994 Sep; 157(2):353-68. PubMed ID: 7520837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis.
    Berrih S; Morel E; Gaud C; Raimond F; Le Brigand H; Bach JF
    Neurology; 1984 Jan; 34(1):66-71. PubMed ID: 6228745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG).
    Ma CG; Zhang GX; Xiao BG; Link H
    Clin Exp Immunol; 1996 Jun; 104(3):509-16. PubMed ID: 9099937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoclonal anti-acetylcholine receptor antibodies with differing capacities to induce experimental autoimmune myasthenia gravis.
    Gomez CM; Richman DP
    J Immunol; 1985 Jul; 135(1):234-41. PubMed ID: 3873489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The auto-anti-idiotypic route to antireceptor antibodies.
    Erlanger BF; Cleveland WL; Wassermann NH; Ku HH; Hill BL; Wan KK; Sarangarajan R; Penn AS
    Ann N Y Acad Sci; 1986; 475():219-26. PubMed ID: 3491562
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies.
    Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH
    J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of T cell specificity on the heterogeneity and disease-causing capability of antibody against the acetylcholine receptor.
    Yeh TM; Krolick KA
    J Neuroimmunol; 1987 Dec; 17(1):17-34. PubMed ID: 2960692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The I-Abm12 mutation, which confers resistance to experimental myasthenia gravis, drastically affects the epitope repertoire of murine CD4+ cells sensitized to nicotinic acetylcholine receptor.
    Bellone M; Ostlie N; Lei SJ; Wu XD; Conti-Tronconi BM
    J Immunol; 1991 Sep; 147(5):1484-91. PubMed ID: 1715360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of experimental autoimmune myasthenia gravis by manipulation of the immune network with a complementary peptide for the acetylcholine receptor.
    Araga S; LeBoeuf RD; Blalock JE
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8747-51. PubMed ID: 8378359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The start of an autoimmune disease: idiotypic network during early progression of myasthenia gravis.
    Lefvert AK
    Ann Inst Pasteur Immunol; 1988; 139(6):633-43. PubMed ID: 3264703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A possible cause of myasthenia gravis: idiotypic networks involving bacterial antigens.
    Dwyer DS; Vakil M; Bradley RJ; Oh SJ; Kearney JF
    Ann N Y Acad Sci; 1987; 505():461-71. PubMed ID: 2446558
    [No Abstract]   [Full Text] [Related]  

  • 37. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
    Graus Y; Meng F; Vincent A; van Breda Vriesman P; de Baets M
    J Immunol; 1995 Jun; 154(12):6382-96. PubMed ID: 7539019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Both CD4+ and CD8+ T cells are essential to induce experimental autoimmune myasthenia gravis.
    Zhang GX; Xiao BG; Bakhiet M; van der Meide P; Wigzell H; Link H; Olsson T
    J Exp Med; 1996 Aug; 184(2):349-56. PubMed ID: 8760788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neonatal tolerance to an immunodominant T cell reactivity does not confer resistance to EAMG induction in Lewis rats.
    Zoda TE; Brandon K; Krolick KA
    J Neuroimmunol; 1995 Mar; 57(1-2):35-44. PubMed ID: 7535790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant human acetylcholine receptor alpha-subunit induces chronic experimental autoimmune myasthenia gravis.
    Lennon VA; Lambert EH; Leiby KR; Okarma TB; Talib S
    J Immunol; 1991 Apr; 146(7):2245-8. PubMed ID: 2005394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.